Latest Insider Transactions at Inspire Medical Systems, Inc. (INSP)
This section provides a real-time view of insider transactions for Inspire Medical Systems, Inc. (INSP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inspire Medical Systems, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inspire Medical Systems, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 10
2022
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
65
+3.19%
|
$14,755
$227.56 P/Share
|
|
Jan 10
2022
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
60
+33.52%
|
$13,620
$227.56 P/Share
|
|
Jan 10
2022
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
101
+2.65%
|
$22,927
$227.56 P/Share
|
|
Jan 10
2022
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
57
+16.81%
|
$12,939
$227.56 P/Share
|
|
Jan 05
2022
|
Randy Ban Officer |
SELL
Open market or private sale
|
Direct |
3,532
-93.0%
|
$861,808
$244.67 P/Share
|
|
Jan 05
2022
|
Randy Ban Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,532
+48.19%
|
$7,064
$2.07 P/Share
|
|
Jan 04
2022
|
Randy Ban Officer |
SELL
Open market or private sale
|
Direct |
6,775
-96.22%
|
$1,626,000
$240.0 P/Share
|
|
Jan 04
2022
|
Randy Ban Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,775
+34.26%
|
$6,775
$1.51 P/Share
|
|
Dec 27
2021
|
Randy Ban Officer |
SELL
Open market or private sale
|
Direct |
1,418
-85.11%
|
$340,320
$240.0 P/Share
|
|
Dec 27
2021
|
Randy Ban Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,418
+36.81%
|
$1,418
$1.51 P/Share
|
|
Dec 23
2021
|
Randy Ban Officer |
SELL
Open market or private sale
|
Direct |
8,342
-97.11%
|
$2,002,080
$240.0 P/Share
|
|
Dec 23
2021
|
Randy Ban Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,342
+43.45%
|
$8,342
$1.51 P/Share
|
|
Dec 07
2021
|
Marilyn C Nelson Director |
SELL
Open market or private sale
|
Indirect |
25,106
-19.89%
|
$5,397,790
$215.0 P/Share
|
|
Nov 20
2021
|
Timothy P. Herbert CEO and President |
BUY
Bona fide gift
|
Direct |
8,420
+4.48%
|
-
|
|
Nov 20
2021
|
Timothy P. Herbert CEO and President |
SELL
Bona fide gift
|
Indirect |
8,420
-87.26%
|
-
|
|
Nov 06
2021
|
Marilyn C Nelson Director |
SELL
Bona fide gift
|
Indirect |
11,781
-8.54%
|
-
|
|
Oct 15
2021
|
Steven Jandrich VP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+36.33%
|
$0
$0.94 P/Share
|
|
Oct 08
2021
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
100
+2.7%
|
$23,100
$231.04 P/Share
|
|
Oct 08
2021
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
64
+0.33%
|
$14,784
$231.04 P/Share
|
|
Oct 08
2021
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
64
+3.24%
|
$14,784
$231.04 P/Share
|
|
Oct 08
2021
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
59
+50.0%
|
$13,629
$231.04 P/Share
|
|
Oct 08
2021
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
56
+19.93%
|
$12,936
$231.04 P/Share
|
|
Sep 28
2021
|
Richard Buchholz Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,755
+2.49%
|
$80,835
$17.82 P/Share
|
|
Sep 02
2021
|
Timothy P. Herbert CEO and President |
SELL
Bona fide gift
|
Indirect |
3,500
-40.12%
|
-
|
|
Aug 20
2021
|
Georgia Melenikiotou Director |
SELL
Open market or private sale
|
Direct |
566
-87.63%
|
$119,992
$212.14 P/Share
|
|
Aug 20
2021
|
Georgia Melenikiotou Director |
BUY
Exercise of conversion of derivative security
|
Direct |
426
+42.94%
|
$39,618
$93.14 P/Share
|
|
Aug 19
2021
|
Georgia Melenikiotou Director |
SELL
Open market or private sale
|
Direct |
140
-50.0%
|
$28,840
$206.97 P/Share
|
|
Aug 18
2021
|
Georgia Melenikiotou Director |
SELL
Open market or private sale
|
Direct |
852
-75.27%
|
$176,364
$207.08 P/Share
|
|
Aug 18
2021
|
Georgia Melenikiotou Director |
BUY
Exercise of conversion of derivative security
|
Direct |
852
+42.94%
|
$79,236
$93.14 P/Share
|
|
Jul 09
2021
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
78
+0.41%
|
$14,430
$185.73 P/Share
|
|
Jul 09
2021
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
78
+4.05%
|
$14,430
$185.73 P/Share
|
|
Jul 09
2021
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
71
+20.23%
|
$13,135
$185.73 P/Share
|
|
Jul 09
2021
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
120
+3.31%
|
$22,200
$185.73 P/Share
|
|
Jul 09
2021
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
68
+28.69%
|
$12,580
$185.73 P/Share
|
|
Apr 09
2021
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
62
+0.32%
|
$13,516
$218.45 P/Share
|
|
Apr 09
2021
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
62
+3.39%
|
$13,516
$218.45 P/Share
|
|
Apr 09
2021
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
57
+21.43%
|
$12,426
$218.45 P/Share
|
|
Apr 09
2021
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
94
+2.7%
|
$20,492
$218.45 P/Share
|
|
Apr 09
2021
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
54
+34.84%
|
$11,772
$218.45 P/Share
|
|
Mar 12
2021
|
Richard Buchholz Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+4.37%
|
$312,500
$25.08 P/Share
|
|
Feb 26
2021
|
Steven Jandrich VP, Human Resources |
SELL
Open market or private sale
|
Direct |
10,000
-86.92%
|
$2,350,000
$235.0 P/Share
|
|
Feb 26
2021
|
Steven Jandrich VP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+25.04%
|
$260,000
$26.27 P/Share
|
|
Feb 25
2021
|
Richard Buchholz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-5.75%
|
$4,520,000
$226.11 P/Share
|
|
Jan 29
2021
|
Bryan K Phillips Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,275
+50.0%
|
-
|
|
Jan 21
2021
|
Richard Buchholz Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
480
+10.71%
|
-
|
|
Jan 21
2021
|
Richard Buchholz Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
480
-1.05%
|
-
|
|
Jan 08
2021
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
64
+29.63%
|
$12,416
$194.1 P/Share
|
|
Jan 08
2021
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
70
+3.94%
|
$13,580
$194.1 P/Share
|
|
Jan 08
2021
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
106
+3.12%
|
$20,564
$194.1 P/Share
|
|
Jan 08
2021
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
70
+0.37%
|
$13,580
$194.1 P/Share
|